- Creso Pharma’s (CPH) wholly-owned Canadian subsidiary Mernova Medicinal receives a maiden order for its Ritual Gold vaporiser products
- The order comes from the Weed Pool Cannabis Cooperative in Saskatchewan and consists of 40 cases of one-gram lemon haze vaporisers valued at C$11,088 (A$12,420)
- The Ritual Gold Range is Creso Pharma’s handheld vaporiser that marks an entry into the rapidly growing cannabis vaporiser market
- As the one-gram product uses cannabis trim and other biomass not optimal for retail sale, it could potentially increase Mernova’s revenue from unused inventory
- Creso Pharma ends the day in the grey with shares trading at 3.7 cents
Creso Pharma’s (CPH) wholly-owned Canadian subsidiary Mernova Medicinal has received a maiden order for its Ritual Gold vaporiser products.
The order comes from the Weed Pool Cannabis Cooperative in Saskatchewan and consists of 40 cases of one-gram lemon haze vaporisers and is valued at C$11,088 (A$12,420).
The Ritual Gold Range is Creso Pharma’s handheld vaporiser that marks an entry into the rapidly growing cannabis vaporiser market.
It uses Mernova’s indoor grown, hand-trimmed, hang dried, cured high-THC cannabis flower.
As the one-gram product uses cannabis trim and other biomass not optimal for retail sale, it could potentially increase Mernova’s revenue from unused inventory.
Mernova has also begun participating in the Ontario Cannabis Store’s (OCS) retail flow through program via its Black Mamba and Mac 1 strains.
Retail stores in Canada now have direct access to Mernova’s products via a specialised distribution platform, resulting in the potential to increase purchase orders
“Mernova has continued to advance a number of initiatives which have the potential to significantly increase its reach, streamline distribution and underpin future sales growth,” CEO and Managing Director William Lay said.
“We are excited to have secured our maiden purchase order for the Ritual Gold range and look forward to gaining valuable feedback from customers in Saskatchewan.
“Ritual Gold is an important launch for Mernova that provides access to a large and growing market, and reduces the amount of dried flower wastage coming from our facility.”
Creso Pharma has ended the day in the grey with shares trading at 3.7 cents.